Celularity Statistics
Share Statistics
Celularity has 23.81M
shares outstanding. The number of shares has increased by 9.3%
in one year.
| Shares Outstanding | 23.81M |
| Shares Change (YoY) | 9.3% |
| Shares Change (QoQ) | 5.89% |
| Owned by Institutions (%) | 0.05% |
| Shares Floating | n/a |
| Failed to Deliver (FTD) Shares | 13,148 |
| FTD / Avg. Volume | 10.7% |
Short Selling Information
The latest short interest is 1.65M, so 6.91% of the outstanding
shares have been sold short.
| Short Interest | 1.65M |
| Short % of Shares Out | 6.91% |
| Short % of Float | 29.8% |
| Short Ratio (days to cover) | 26.56 |
Valuation Ratios
The PE ratio is -0.22 and the forward
PE ratio is -0.36.
Celularity's PEG ratio is
0.
| PE Ratio | -0.22 |
| Forward PE | -0.36 |
| PS Ratio | 1.93 |
| Forward PS | 0.1 |
| PB Ratio | 1.07 |
| P/FCF Ratio | -1.03 |
| PEG Ratio | 0 |
Financial Ratio HistoryEnterprise Valuation
Currently the Enterprise Value (EV) is not available for Celularity.
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 0.29,
with a Debt / Equity ratio of 1.6.
| Current Ratio | 0.29 |
| Quick Ratio | 0.21 |
| Debt / Equity | 1.6 |
| Debt / EBITDA | -0.36 |
| Debt / FCF | -1.53 |
| Interest Coverage | -63.78 |
Financial Efficiency
Return on Equity is n/a and Return on Invested Capital is n/a.
| Return on Equity | n/a |
| Return on Assets | n/a |
| Return on Invested Capital | n/a |
| Revenue Per Employee | $189,758.33 |
| Profits Per Employee | $-1,635,791.67 |
| Employee Count | 120 |
| Asset Turnover | 0.16 |
| Inventory Turnover | 2.78 |
Taxes
| Income Tax | 10K |
| Effective Tax Rate | -0.01% |
Stock Price Statistics
The stock price has increased by -44.26% in the
last 52 weeks. The beta is 0.61, so Celularity's
price volatility has been higher than the market average.
| Beta | 0.61 |
| 52-Week Price Change | -44.26% |
| 50-Day Moving Average | 1.56 |
| 200-Day Moving Average | 2.26 |
| Relative Strength Index (RSI) | 52.94 |
| Average Volume (20 Days) | 122,881 |
Income Statement
In the last 12 months, Celularity had revenue of 22.77M
and earned -196.29M
in profits. Earnings per share was -11.02.
| Revenue | 22.77M |
| Gross Profit | 6.75M |
| Operating Income | -192.29M |
| Net Income | -196.29M |
| EBITDA | -183.95M |
| EBIT | -193.27M |
| Earnings Per Share (EPS) | -11.02 |
Full Income StatementBalance Sheet
The company has 227K in cash and 65.42M in
debt, giving a net cash position of -65.19M.
| Cash & Cash Equivalents | 227K |
| Total Debt | 65.42M |
| Net Cash | -65.19M |
| Retained Earnings | -841.79M |
| Total Assets | 128.84M |
| Working Capital | -61.67M |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was -38.69M
and capital expenditures -4.05M, giving a free cash flow of -42.73M.
| Operating Cash Flow | -38.69M |
| Capital Expenditures | -4.05M |
| Free Cash Flow | -42.73M |
| FCF Per Share | -2.4 |
Full Cash Flow StatementMargins
Gross margin is 29.66%, with operating and profit margins of -844.44% and -862.04%.
| Gross Margin | 29.66% |
| Operating Margin | -844.44% |
| Pretax Margin | -862% |
| Profit Margin | -862.04% |
| EBITDA Margin | -807.81% |
| EBIT Margin | -844.44% |
| FCF Margin | -187.66% |
